IP and Patent Strategy for Spinouts
IP and Patent Strategy for Spinouts helps the founder or programme team create a practical plan for institutional ownership, IP licence, founders, studio/corporate terms and governance. Within University & Research Commercialisation, it turns a broad or uncertain area of the venture into a concrete Bertie work product that can be reviewed, improved and reused. The task is intentionally discrete: it should produce a specific artefact, decision, evidence item or risk signal rather than general learning notes.
Define a practical, sequenced plan for IP and Patent Strategy for Spinouts. The objective is to remove ambiguity around institutional ownership, IP licence, founders, studio/corporate terms and governance, give the founder a decision-ready output, and make it clear whether the venture should progress, repeat the task with stronger evidence, escalate to expert support, or move into a linked stage.
Bertie or a programme manager assigns IP and Patent Strategy for Spinouts when the venture needs a decision-ready output for this group. Typical triggers include group-gate reviews, evidence gaps identified by the co-pilot or founder request.
research asset; IP or publication status; research team; technology maturity; candidate applications; specific context for institutional ownership, IP licence, founders, studio/corporate terms and governance.
Determine the precise commercial destination for the university IP, whether aiming for an exclusive spinout licence, non-exclusive platform licensing, or a joint venture. Map the decision horizon across funding rounds, patent prosecution timelines, and Technology Readiness Levels (TRLs) to align commercialisation milestones.
ObjectiveCompleting this action establishes a clear strategic direction and timeline for the university IP commercialisation route. It ensures the spinout strategy aligns with investor expectations and prevents premature patent filings before commercial viability is proven.
What's expectedThe founder must deliver a documented IP commercialisation statement detailing the target destination, decision horizon, and critical TRL gates. This must include explicit timeline boundaries backed by preliminary market feedback and technology readiness assessments.
Open action arrow_forwardConsultant stress-test · 5 questions- 1.What specific evidence demonstrates that your target commercialisation route matches the current maturity of the underlying IP?
- 2.Why have you chosen this particular decision horizon rather than aligning it directly with your primary seed funding milestones?
- 3.How does your proposed timeline accommodate potential delays in the university's Technology Transfer Office (TTO) approval process?
- 4.What market validation signals would force you to pivot from a spinout model to an arm's-length licensing agreement?
- 5.How does your IP goal account for competing freedom-to-operate constraints within your target market?
- A data-room asset titled IP and Patent Strategy for Spinouts
- A practical plan with owners, sequencing, assumptions, dependencies, risks and next decision points
- It should update the venture DNA with specific evidence or decisions about institutional ownership, IP licence, founders, studio/corporate terms and governance, create a visible milestone in the founder journey, and generate one or more recommended next tasks
Bertie co-pilot translates research language into commercial hypotheses, structures IP and application evidence, and recommends spinout, licence or discovery tasks. For this task, it should focus on institutional ownership, IP licence, founders, studio/corporate terms and governance, prompt the founder for missing inputs, draft or improve the output, flag weak assumptions, and record the result back into the relevant data-room section.
A mentor or evaluator can review the output at the group gate. Programme managers can require an advisor checkpoint before Bertie moves the venture forward.
